FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Dov Kadmon

Research Profile

Disorders

Procedures

Living Beings

Anatomy

Prostate

Chemicals & Drugs

Genes & Molecular Sequences

Co-author Network

Publications

TOP 3
Guru Sonpavde; Ken-Ichi Tabata; Timothy C Thompson; Thomas M Wheeler; Shinji Kurosaka; Brian J Miles; Martha P Mims; Chengzhen Ren; Gustavo E Ayala; Kohei Edamura; Adrian Gee; Alexei A Goltsov; Teresa G Hayes; Michael M Ittmann; Rajul K Jain; Dov Kadmon
GLIPR1 tumor suppressor gene expressed by adenoviral vector as neoadjuvant intraprostatic injection for localized intermediate or high-risk prostate cancer preceding radical prostatectomy.
Gustavo E Ayala; Bahar Muezzinoglu; Kai H Hammerich; Anna Frolov; Hao Liu; Peter T Scardino; Rile Li; Mohammad Sayeeduddin; Michael Ittmann; Dov Kadmon; Brian J Miles; Thomas M Wheeler; David R Rowley
Determining prostate cancer-specific death through quantification of stromogenic carcinoma area in prostatectomy specimens.
Ken-Ichi Tabata; M Watanabe; Koji Naruishi; K Edamura; Takefumi Satoh; Guang Yang; E Abdel Fattah; Jian Wang; Alexei Goltsov; Daniel Floryk; S D Soni; Dov Kadmon; Timothy C Thompson
Therapeutic effects of gelatin matrix-embedded IL-12 gene-modified macrophages in a mouse model of residual prostate cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Dov Kadmon (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Guru Sonpavde; Ken-Ichi Tabata; Timothy C Thompson; Thomas M Wheeler; Shinji Kurosaka; Brian J Miles; Martha P Mims; Chengzhen Ren; Gustavo E Ayala; Kohei Edamura; Adrian Gee; Alexei A Goltsov; Teresa G Hayes; Michael M Ittmann; Rajul K Jain; Dov Kadmon
GLIPR1 tumor suppressor gene expressed by adenoviral vector as neoadjuvant intraprostatic injection for localized intermediate or high-risk prostate cancer preceding radical prostatectomy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(22):7174-82.
2011: Gustavo E Ayala; Bahar Muezzinoglu; Kai H Hammerich; Anna Frolov; Hao Liu; Peter T Scardino; Rile Li; Mohammad Sayeeduddin; Michael Ittmann; Dov Kadmon; Brian J Miles; Thomas M Wheeler; David R Rowley
Determining prostate cancer-specific death through quantification of stromogenic carcinoma area in prostatectomy specimens.
The American journal of pathology 2011;178(1):79-87.
2009: Ken-Ichi Tabata; M Watanabe; Koji Naruishi; K Edamura; Takefumi Satoh; Guang Yang; E Abdel Fattah; Jian Wang; Alexei Goltsov; Daniel Floryk; S D Soni; Dov Kadmon; Timothy C Thompson
Therapeutic effects of gelatin matrix-embedded IL-12 gene-modified macrophages in a mouse model of residual prostate cancer.
Prostate cancer and prostatic diseases 2009;12(3):301-9.
2008: Gustavo E Ayala; Hong Dai; Michael Powell; Rile Li; Yi Ding; Thomas M Wheeler; David Shine; Dov Kadmon; Timothy Thompson; Brian J Miles; Michael M Ittmann; David Rowley
Cancer-related axonogenesis and neurogenesis in prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(23):7593-603.
2008: Gustavo Ayala; Jun Yan; Rile Li; Yi Ding; Timothy C Thompson; Martha P Mims; Teresa G Hayes; Vivian MacDonnell; R Garret Lynch; Anna Frolov; Brian J Miles; Thomas M Wheeler; J Wade Harper; Ming-Jer Tsai; Michael M Ittmann; Dov Kadmon
Bortezomib-mediated inhibition of steroid receptor coactivator-3 degradation leads to activated Akt.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(22):7511-8.
2008: Salahaldin A Tahir; Guang Yang; Alexei Goltsov; Masami Watanabe; Ken-ichi Tabata; Josephine Addai; El Moataz Abdel Fattah; Dov Kadmon; Timothy C Thompson
Tumor cell-secreted caveolin-1 has proangiogenic activities in prostate cancer.
Cancer research 2008;68(3):731-9.
2008: Nobuyuki Yanagisawa; Rile Li; David Rowley; Hao Liu; Dov Kadmon; Brian J Miles; Thomas M Wheeler; Gustavo E Ayala
Reprint of: Stromogenic prostatic carcinoma pattern (carcinomas with reactive stromal grade 3) in needle biopsies predicts biochemical recurrence-free survival in patients after radical prostatectomy.
Human pathology 2008;39(2):282-91.
2007: Guru Sonpavde; Kim N Chi; Thomas Powles; Christopher J Sweeney; Noah Hahn; Thomas E Hutson; Matthew D Galsky; William R Berry; Dov Kadmon
Neoadjuvant therapy followed by prostatectomy for clinically localized prostate cancer.
Cancer 2007;110(12):2628-39.
2007: Nobuyuki Yanagisawa; Rile Li; David Rowley; Hao Liu; Dov Kadmon; Brian J Miles; Thomas M Wheeler; Gustavo E Ayala
Stromogenic prostatic carcinoma pattern (carcinomas with reactive stromal grade 3) in needle biopsies predicts biochemical recurrence-free survival in patients after radical prostatectomy.
Human pathology 2007;38(11):1611-20.
2007: Guang Yang; Josephine Addai; Thomas M Wheeler; Anna Frolov; Brian J Miles; Dov Kadmon; Timothy C Thompson
Correlative evidence that prostate cancer cell-derived caveolin-1 mediates angiogenesis.
Human pathology 2007;38(11):1688-95.
2007: H Wang; Guang Yang; Terry L Timme; T Fujita; Koji Naruishi; Anna Frolov; Malcolm K Brenner; Dov Kadmon; Timothy C Thompson
IL-12 gene-modified bone marrow cell therapy suppresses the development of experimental metastatic prostate cancer.
Cancer gene therapy 2007;14(10):819-27.
2007: Bin S Teh; Michael D Bastasch; Wei-Yuan Mai; Dov Kadmon; Brian J Miles; E. Brian Butler
Preliminary report of the effect of high-dose adjuvant intensity modulated radiation therapy on the sural nerve graft for cavernosal nerve sacrifice after radical prostatectomy.
American journal of clinical oncology 2007;30(4):395-400.
2006: Salahaldin A Tahir; Anna Frolov; Teresa G Hayes; Martha P Mims; Brian J Miles; Seth P Lerner; Thomas M Wheeler; Gustavo Ayala; Timothy C Thompson; Dov Kadmon
Preoperative serum caveolin-1 as a prognostic marker for recurrence in a radical prostatectomy cohort.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(16):4872-5.
2006: Bin S Teh; Michael D Bastasch; Wei-Yuan Mai; Michael W Kattan; E. Brian Butler; Dov Kadmon
Long-term benefits of elective radiotherapy after prostatectomy for patients with positive surgical margins.
The Journal of urology 2006;175(6):2097-101; discussion 2101-2.
2006: Gustavo Ayala; Takefumi Satoh; Rile Li; Moshe Shalev; Yehoshua Gdor; Estuardo Aguilar-Cordova; Anna Frolov; Thomas M Wheeler; Brian J Miles; Kate Rauen; Bin S Teh; E. Brian Butler; Timothy C Thompson; Dov Kadmon
Biological response determinants in HSV-tk + ganciclovir gene therapy for prostate cancer.
Molecular therapy : the journal of the American Society of Gene Therapy 2006;13(4):716-28.
2006: Michael T Tetzlaff; Bin S Teh; Terry L Timme; Tetsuo Fujita; Takefumi Satoh; Ken-Ichi Tabata; Wei-Yuan Mai; Maria T Vlachaki; Robert J Amato; Dov Kadmon; Brian J Miles; Gustavo Ayala; Thomas M Wheeler; Estuardo Aguilar-Cordova; Timothy C Thompson; E. Brian Butler
Expanding the therapeutic index of radiation therapy by combining in situ gene therapy in the treatment of prostate cancer.
Technology in cancer research & treatment 2006;5(1):23-36.
2006: Moon S Koh; Michael Ittmann; Dov Kadmon; Timothy C Thompson; Fredrick S Leach
CDC4 gene expression as potential biomarker for targeted therapy in prostate cancer.
Cancer biology & therapy 2006;5(1):78-83.
2005: R R M van der Linden; Bart L Haagmans; P Mongiat-Artus; G J van Doornum; Robert Kraaij; Dov Kadmon; Estuardo Aguilar-Cordova; A D M E Osterhaus; Theo Van der Kwast; Chris H Bangma
Virus specific immune responses after human neoadjuvant adenovirus-mediated suicide gene therapy for prostate cancer.
European urology 2005;48(1):153-61.
2005: Mfon S Cyrus-David; Armin Weinberg; Timothy Thompson; Dov Kadmon
The effect of statins on serum prostate specific antigen levels in a cohort of airline pilots: a preliminary report.
The Journal of urology 2005;173(6):1923-5.
2005: L Li; M M Ittmann; Gustavo Ayala; M-J Tsai; R J Amato; T M Wheeler; Brian J Miles; Dov Kadmon; Timothy C Thompson
The emerging role of the PI3-K-Akt pathway in prostate cancer progression.
Prostate cancer and prostatic diseases 2005;8(2):108-18.
2005: Pierre I Karakiewicz; Shahrokh F Shariat; Amir Naderi; Dov Kadmon; Kevin Slawin
Reliability of remembered International Index of Erectile Function domain scores in men with localized prostate cancer.
Urology 2005;65(1):131-5.
2004: Eduardo I Canto; Herb Singh; Shahrokh F Shariat; Dov Kadmon; Brian J Miles; Thomas M Wheeler; Kevin Slawin
Effects of systematic 12-core biopsy on the performance of percent free prostate specific antigen for prostate cancer detection.
The Journal of urology 2004;172(3):900-4.
2004: Takefumi Satoh; Bin S Teh; Terry L Timme; Wei-Yuan Mai; Yehoshua Gdor; Nobuyuki Kusaka; Tetsuo Fujita; Christins K Pramudji; Maria T Vlachaki; Gustavo Ayala; Thomas Wheeler; Robert J Amato; Brian J Miles; Dov Kadmon; E. Brian Butler; Timothy C Thompson
Enhanced systemic T-cell activation after in situ gene therapy with radiotherapy in prostate cancer patients.
International journal of radiation oncology, biology, physics 2004;59(2):562-71.
2004: Eduardo I Canto; Herb Singh; Shahrokh F Shariat; Dolores J Lamb; Stephen D Mikolajczyk; Harry J Linton; Harry G Rittenhouse; Dov Kadmon; Brian J Miles; Kevin Slawin
Serum BPSA outperforms both total PSA and free PSA as a predictor of prostatic enlargement in men without prostate cancer.
Urology 2004;63(5):905-10; discussion 910-1.
2004: Herb Singh; Eduardo I Canto; Shahrokh F Shariat; Dov Kadmon; Brian J Miles; Thomas M Wheeler; Kevin Slawin
Predictors of prostate cancer after initial negative systematic 12 core biopsy.
The Journal of urology 2004;171(5):1850-4.
2004: Bin S Teh; Gustavo Ayala; Laura K Aguilar; Wei-Yuan Mai; Terry L Timme; Maria T Vlachaki; Brian J Miles; Dov Kadmon; Thomas Wheeler; James Caillouet; Maria Davis; L Steven Carpenter; Hsin H Lu; J Kam Chiu; Shiao Y Woo; Timothy Thompson; Estuardo Aguilar-Cordova; E. Brian Butler
Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.
International journal of radiation oncology, biology, physics 2004;58(5):1520-9.
2004: Herb Singh; Eduardo I Canto; Shahrokh F Shariat; Dov Kadmon; Brian J Miles; Thomas M Wheeler; Kevin Slawin
Improved detection of clinically significant, curable prostate cancer with systematic 12-core biopsy.
The Journal of urology 2004;171(3):1089-92.
2004: Herb Singh; Eduardo I Canto; Shahrokh F Shariat; Dov Kadmon; Brian J Miles; Thomas M Wheeler; Kevin Slawin
Six additional systematic lateral cores enhance sextant biopsy prediction of pathological features at radical prostatectomy.
The Journal of urology 2004;171(1):204-9.
2003: Guangwen Cao; Guang Yang; Terry L Timme; Takashi Saika; Luan D Truong; Takefumi Satoh; Alexei Goltsov; Sang Hee Park; Taoyan Men; Nobuyuki Kusaka; Weihua Tian; Chengzhen Ren; Hongyu Wang; Dov Kadmon; Wei-Wen Cai; A Craig Chinault; Timothy B Boone; Allan Bradley; Timothy C Thompson
Disruption of the caveolin-1 gene impairs renal calcium reabsorption and leads to hypercalciuria and urolithiasis.
The American journal of pathology 2003;162(4):1241-8.
2003: Terry L Timme; Takefumi Satoh; Salahaldin A Tahir; Hongyu Wang; Bin S Teh; E. Brian Butler; Brian J Miles; Robert J Amato; Dov Kadmon; Timothy C Thompson
Therapeutic targets for metastatic prostate cancer.
Current drug targets 2003;4(3):251-61.
2002: Vladimir Mouraviev; Likun Li; Salahaldin A Tahir; Guang Yang; Terry M Timme; Alexei Goltsov; Chengzhen Ren; Takefumi Satoh; Thomas M Wheeler; Michael Ittmann; Brian J Miles; Robert J Amato; Dov Kadmon; Timothy C Thompson
The role of caveolin-1 in androgen insensitive prostate cancer.
The Journal of urology 2002;168(4 Pt 1):1589-96.
2002: Michael D Bastasch; Bin S Teh; Wei-Yuan Mai; L Steven Carpenter; Hsin H Lu; J Kam Chiu; Shiao Y Woo; Walter H Grant; Brian J Miles; Dov Kadmon; E. Brian Butler
Post-nerve-sparing prostatectomy, dose-escalated intensity-modulated radiotherapy: effect on erectile function.
International journal of radiation oncology, biology, physics 2002;54(1):101-6.
2002: Yehoshua Gdor; Terry L Timme; Brian J Miles; Dov Kadmon; Timothy C Thompson
Gene therapy for prostate cancer.
Expert review of anticancer therapy 2002;2(3):309-21.
2002: Alvin M Matsumoto; Lisa Tenover; Michael McClung; David Mobley; Jack Geller; Michael Sullivan; John Grayhack; Hunter Wessells; Dov Kadmon; Malachi Flanagan; Gang K Zhang; Joseph Schmidt; Alice M Taylor; Michael Lee; Joanne Waldstreicher
The long-term effect of specific type II 5alpha-reductase inhibition with finasteride on bone mineral density in men: results of a 4-year placebo controlled trial.
The Journal of urology 2002;167(5):2105-8.
2002: Dov Kadmon
Radiation therapy after radical prostatectomy: strike early, strike hard! The case for adjuvant radiation therapy.
Reviews in urology 2002;4(2):87-9.
2002: Bin S Teh; Estuardo Aguilar-Cordova; Maria T Vlachaki; Laura K Aguilar; Wei-Yuan Mai; James Caillouet; Maria Davis; Brian J Miles; Dov Kadmon; Gustavo Ayala; Hsin H Lu; J Kam Chiu; L Steven Carpenter; Shiao Y Woo; Walter H Grant; Thomas Wheeler; Timothy C Thompson; E. Brian Butler
Combining radiotherapy with gene therapy (from the bench to the bedside): a novel treatment strategy for prostate cancer.
The oncologist 2002;7(5):458-66.
2001: Edward D Kim; R Nath; Kevin Slawin; Dov Kadmon; B J Miles; Peter T Scardino
Bilateral nerve grafting during radical retropubic prostatectomy: extended follow-up.
Urology 2001;58(6):983-7.
2001: Brian J Miles; Moshe Shalev; Estuardo Aguilar-Cordova; Terry L Timme; H M Lee; Guang Yang; HL Adler; Kenneth Kernen; Christins K Pramudji; Takefumi Satoh; Yehoshua Gdor; Chengzhen Ren; Gustavo Ayala; Thomas M Wheeler; E. Brian Butler; Dov Kadmon; Timothy C Thompson
Prostate-specific antigen response and systemic T cell activation after in situ gene therapy in prostate cancer patients failing radiotherapy.
Human gene therapy 2001;12(16):1955-67.
2001: Bin S Teh; Estuardo Aguilar-Cordova; Kenneth Kernen; C C Chou; Moshe Shalev; Maria T Vlachaki; Brian J Miles; Dov Kadmon; Wei-Yuan Mai; James Caillouet; Maria Davis; Gustavo Ayala; Thomas Wheeler; J Brady; L Steven Carpenter; Hsin H Lu; J Kam Chiu; Shiao Y Woo; Timothy Thompson; E. Brian Butler
Phase I/II trial evaluating combined radiotherapy and in situ gene therapy with or without hormonal therapy in the treatment of prostate cancer--a preliminary report.
International journal of radiation oncology, biology, physics 2001;51(3):605-13.
2001: Edward D Kim; R Nath; Dov Kadmon; Larry I Lipshultz; Brian J Miles; Kevin Slawin; Hsiao-Yuan Tang; Thomas Wheeler; Peter T Scardino
Bilateral nerve graft during radical retropubic prostatectomy: 1-year followup.
The Journal of urology 2001;165(6 Pt 1):1950-6.
2001: T C Thompson; Terry L Timme; S Ebara; T Satoh; G Yang; J Wang; B J Miles; G Ayala; T M Wheeler; Dov Kadmon
In situ gene therapy for prostate cancer: immunomodulatory approaches.
Expert opinion on biological therapy 2001;1(3):481-95.
2001: J L Gore; Shahrokh F Shariat; Brian J Miles; Dov Kadmon; N Jiang; Thomas M Wheeler; Kevin Slawin
Optimal combinations of systematic sextant and laterally directed biopsies for the detection of prostate cancer.
The Journal of urology 2001;165(5):1554-9.
2001: S W Sukin; Madhu Chhikara; Xiaohong Zhu; Gustavo Ayala; Laura K Aguilar; E O'Brian Smith; Brian J Miles; Timothy C Thompson; Dov Kadmon; Estuardo Aguilar-Cordova
In vivo surgical resection plus adjuvant gene therapy in the treatment of mammary and prostate cancer.
Molecular therapy : the journal of the American Society of Gene Therapy 2001;3(4):500-6.
2001: Edward D Kim; Peter T Scardino; Dov Kadmon; Kevin Slawin; Rahul K Nath
Interposition sural nerve grafting during radical retropubic prostatectomy.
Urology 2001;57(2):211-6.
2001: Moshe Shalev; Timothy C Thompson; Dov Kadmon; Gustavo Ayala; Kenneth Kernen; Brian J Miles
Gene therapy for prostate cancer.
Urology 2001;57(1):8-16.
2000: Christina Thaller; M Shalev; A Frolov; Gregor Eichele; Timothy C Thompson; R H Williams; O Dillioglugil; Dov Kadmon
Fenretinide therapy in prostate cancer: effects on tissue and serum retinoid concentration.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(22):3804-8.
2000: Gustavo Ayala; Thomas M Wheeler; Moshe Shalev; Timothy C Thompson; Brian J Miles; Estuardo Aguilar-Cordova; S Chakraborty; Dov Kadmon
Cytopathic effect of in situ gene therapy in prostate cancer.
Human pathology 2000;31(7):866-70.
2000: Moshe Shalev; Dov Kadmon; Bin S Teh; E. Brian Butler; Estuardo Aguilar-Cordova; Timothy C Thompson; JR Herman; HL Adler; Peter T Scardino; Brian J Miles
Suicide gene therapy toxicity after multiple and repeat injections in patients with localized prostate cancer.
The Journal of urology 2000;163(6):1747-50.
2000: V C Smith; Robert Edwards; Jeffrey L Jorgensen; R A Goldfarb; Dov Kadmon; Philip T Cagle; Luan D Truong
Unilocular retroperitoneal cyst of mesothelial origin presenting as a renal mass.
Archives of pathology & laboratory medicine 2000;124(5):766-9.
2000: Moshe Shalev; Brian J Miles; Timothy C Thompson; Gustavo Ayala; E. Brian Butler; Estuardo Aguilar-Cordova; Dov Kadmon
Suicide gene therapy for prostate cancer using a replication-deficient adenovirus containing the herpesvirus thymidine kinase gene.
World journal of urology 2000;18(2):125-9.
2000: M R Shaker; G Yang; Terry L Timme; S H Park; Dov Kadmon; C Ren; X Ji; H M Lee; I Sehgal; M Anzano; Michael B. Sporn; Timothy C Thompson
Dietary 4-HPR suppresses the development of bone metastasis in vivo in a mouse model of prostate cancer progression.
Clinical & experimental metastasis 2000;18(5):429-38.
2000: Y Lotan; X C Xu; M Shalev; R Lotan; R Williams; Thomas M Wheeler; Timothy C Thompson; Dov Kadmon
Differential expression of nuclear retinoid receptors in normal and malignant prostates.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(1):116-21.
1999: Christopher P Smith; A Sharma; G Ayala; Philip T Cagle; Dov Kadmon
Solitary pulmonary metastasis from prostate cancer.
The Journal of urology 1999;162(6):2102.
1998: Gerald L Andriole; Harry A Guess; Jonathan I Epstein; H Wise; Dov Kadmon; E D Crawford; P Hudson; C L Jackson; Nicholas A Romas; L Patterson; Thomas J Cook; Joanne Waldstreicher
Treatment with finasteride preserves usefulness of prostate-specific antigen in the detection of prostate cancer: results of a randomized, double-blind, placebo-controlled clinical trial. PLESS Study Group. Proscar Long-term Efficacy and Safety Study.
Urology 1998;52(2):195-201; discussion 201-2.
1998: Paula F Leis; KR Stevens; Susan Baer; Dov Kadmon; Leonard H Goldberg; Xiao-Jing Wang
A c-rasHa mutation in the metastasis of a human papillomavirus (HPV)-18 positive penile squamous cell carcinoma suggests a cooperative effect between HPV-18 and c-rasHa activation in malignant progression.
Cancer 1998;83(1):122-9.
1996: MA Sutton; H L Watkins; Linda K Green; Dov Kadmon
Intracranial metastases as the first manifestation of prostate cancer.
Urology 1996;48(5):789-93.
1996: Dov Kadmon; A D Weinberg; R H Williams; Valory N Pavlik; P Cooper; P J Migliore
Pitfalls in interpreting prostate specific antigen velocity.
The Journal of urology 1996;155(5):1655-7.
1996: Terry L Timme; Guang Yang; E Rogers; Dov Kadmon; J P Morganstern; S H Park; Timothy C Thompson
Retroviral transduction of transforming growth factor-beta1 induces pleiotropic benign prostatic growth abnormalities in mouse prostate reconstitutions.
Laboratory investigation; a journal of technical methods and pathology 1996;74(4):747-60.
1995: Timothy C Thompson; S H Park; Terry L Timme; Chengzhen Ren; James A Eastham; Lawrence A Donehower; Allan Bradley; Dov Kadmon; Guang Yang
Loss of p53 function leads to metastasis in ras+myc-initiated mouse prostate cancer.
Oncogene 1995;10(5):869-79.
1995: Terry L Timme; Luan D Truong; Kevin Slawin; Dov Kadmon; S H Park; Timothy C Thompson
Mesenchymal-epithelial interactions and transforming growth factor-beta 1 expression during normal and abnormal prostatic growth.
Microscopy research and technique 1995;30(4):333-41.
1995: Terry L Timme; G Yang; Luan D Truong; Dov Kadmon; S H Park; Timothy C Thompson
Transforming growth factor-beta localization during mouse prostate morphogenesis and in prostatic growth abnormalities.
World journal of urology 1995;13(6):324-8.
1994: D Feeney; E T Quesada; D M Sirbasku; Dov Kadmon
Transitional cell carcinoma in a tuberculous kidney: case report and review of the literature.
The Journal of urology 1994;151(4):989-91.
1994: Terry L Timme; Luan D Truong; V W Merz; T Krebs; Dov Kadmon; K C Flanders; S H Park; Timothy C Thompson
Mesenchymal-epithelial interactions and transforming growth factor-beta expression during mouse prostate morphogenesis.
Endocrinology 1994;134(3):1039-45.
1993: Kevin Slawin; Dov Kadmon; S H Park; Peter T Scardino; M Anzano; Michael B. Sporn; Timothy C Thompson
Dietary fenretinide, a synthetic retinoid, decreases the tumor incidence and the tumor mass of ras+myc-induced carcinomas in the mouse prostate reconstitution model system.
Cancer research 1993;53(19):4461-5.
1993: Timothy C Thompson; Luan D Truong; Terry L Timme; Dov Kadmon; B K McCune; K C Flanders; Peter T Scardino; S H Park
Transgenic models for the study of prostate cancer.
Cancer 1993;71(3 Suppl):1165-71.
1993: Timothy C Thompson; Terry L Timme; Dov Kadmon; S H Park; S Egawa; K Yoshida
Genetic predisposition and mesenchymal-epithelial interactions in ras+myc-induced carcinogenesis in reconstituted mouse prostate.
Molecular carcinogenesis 1993;7(3):165-79.
1993: Luan D Truong; Dov Kadmon; B K McCune; K C Flanders; Peter T Scardino; Timothy C Thompson
Association of transforming growth factor-beta 1 with prostate cancer: an immunohistochemical study.
Human pathology 1993;24(1):4-9.
1992: Timothy C Thompson; S Egawa; Dov Kadmon; G J Miller; Terry L Timme; Peter T Scardino; S H Park
Androgen sensitivity and gene expression in ras + myc-induced mouse prostate carcinomas.
The Journal of steroid biochemistry and molecular biology 1992;43(1-3):79-85.
1992: S Egawa; Dov Kadmon; G J Miller; Peter T Scardino; Timothy C Thompson
Alterations in mRNA levels for growth-related genes after transplantation into castrated hosts in oncogene-induced clonal mouse prostate carcinoma.
Molecular carcinogenesis 1992;5(1):52-61.
1992: Timothy C Thompson; Luan D Truong; Terry L Timme; Dov Kadmon; B K McCune; K C Flanders; Peter T Scardino; S H Park
Transforming growth factor beta 1 as a biomarker for prostate cancer.
Journal of cellular biochemistry. Supplement 1992;16H():54-61.
1992: Dov Kadmon
Chemoprevention in prostate cancer: the role of difluoromethylornithine (DFMO).
Journal of cellular biochemistry. Supplement 1992;16H():122-7.
1991: Dov Kadmon; Timothy C Thompson; G R Lynch; Peter T Scardino
Elevated plasma chromogranin-A concentrations in prostatic carcinoma.
The Journal of urology 1991;146(2):358-61.
1991: V W Merz; G J Miller; T Krebs; Terry L Timme; Dov Kadmon; S H Park; S Egawa; Peter T Scardino; Timothy C Thompson
Elevated transforming growth factor-beta 1 and beta 3 mRNA levels are associated with ras + myc-induced carcinomas in reconstituted mouse prostate: evidence for a paracrine role during progression.
Molecular endocrinology (Baltimore, Md.) 1991;5(4):503-13.
1991: Timothy C Thompson; Dov Kadmon; Terry L Timme; V W Merz; S Egawa; T Krebs; Peter T Scardino; S H Park
Experimental oncogene induced prostate cancer.
Cancer surveys 1991;11():55-71.
1989: Ridwan Shabsigh; S Lerner; I J Fishman; Dov Kadmon
The role of transrectal ultrasonography in the diagnosis and management of prostatic and seminal vesicle cysts.
The Journal of urology 1989;141(5):1206-9.